Novelix Pharmaceuticals Limited has made a regulatory disclosure to BSE Limited regarding authorization of Key Managerial Personnel for materiality determinations under SEBI Listing Regulations.
The Board of Directors of the Company have severally authorized the following Key Managerial Personnel to determine the materiality of an event or information and make necessary disclosures to stock exchanges under Regulation 30 of SEBI Listing Regulations:
- Venkateshwarlu Pulluru (Whole-time Director) - Contact: info@novelixpharma.com
- Bhoomika Choudhary (CFO) - Contact: cfo@novelixpharma.com
- Nishita Kalantri (Company Secretary & Compliance Officer) - Contact: novelixpharmaceuticals@gmail.com
The authorization was made pursuant to Regulation 30(5) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and the Company's Policy for Determination of Materiality of Events or Information.
Company address: H No: 3-6-237/610, Flat No: 610, 6th Floor, Lingapur LA Builders (Also Known as Amrutha Estates), Himayat Nagar, Hyderabad, Telangana-500029. Phone: +91 8977631044, Email: novelixpharmaceuticals@gmail.com, Website: www.novelixpharma.com.
The company was formerly known as TRIMURTHI LIMITED.